MarketPeel
Insider Trading Intelligence
Pricing
…
CB

Carmen Bozic

VRTX
EVP AND CMO · VERTEX PHARMACEUTICALS INC / MA · CIK 0001790029
FILING MIX · LIFETIME29%/71%
BUYS
19
SELLS
47
TOTAL VALUE
$52.32M
COMPANIES
1
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
15,337
AVG SELL PX
$397.47
TRADE KIND
SHOWING 66 / 66
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
15 backtested trades · 8 horizons · 12 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Carmen Bozic, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d15+60.00%-0.01%+0.69%-0.71%-0.77%—
14d15+53.33%-0.13%+0.59%-0.71%-0.91%—
30d15+46.67%+0.08%+1.99%-1.90%-1.05%—
60d15+46.67%+1.85%+5.01%-3.05%-1.63%—
90d15+40.00%+5.10%+8.72%-2.38%-2.04%—
180d15(3 pending)+33.33%+4.18%+15.32%-11.14%-11.46%—
1y15(3 pending)+41.67%+13.75%+24.48%-10.73%-10.80%—
2y15(6 pending)+33.33%+8.15%+50.80%-41.48%-43.66%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
VRTX · 15,337 shares · as of Jun 26, 2026
019,49138,98258,47377,964202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 19 buys / 47 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE10b5-1
10b5-1 plan
596$482.50$287.6K15,337Jun 26, 2026Jun 30, 2026 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE10b5-1
10b5-1 plan
1,020$462.17$471.4K15,933Jun 18, 2026Jun 23, 2026 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE10b5-1
10b5-1 plan
4,062$450.00$1.83M16,953Jun 15, 2026Jun 17, 2026 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE10b5-1
10b5-1 plan
1,745$450.00$785.3K21,015Jun 5, 2026Jun 9, 2026 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE10b5-1
10b5-1 plan
1,974$450.00$888.3K22,760May 29, 2026Jun 2, 2026 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE10b5-1
10b5-1 plan
1,354$453.45$614.0K24,734May 15, 2026May 19, 2026 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE10b5-1
10b5-1 plan
6,988$450.00$3.14M26,088May 12, 2026May 14, 2026 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE10b5-1
10b5-1 plan
2,329$450.95$1.05M33,076Mar 27, 2026Mar 31, 2026 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE10b5-1
10b5-1 plan
2,329$481.79$1.12M35,405Mar 13, 2026Mar 17, 2026 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE10b5-1
10b5-1 plan
2,329$480.31$1.12M37,734Feb 27, 2026Mar 3, 2026 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
EVP and CMO
1,453$485.11$704.9K40,063Feb 24, 2026Feb 26, 2026 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
PURCHASEGRANT
Stock grant
5,375——43,428Feb 17, 2026Feb 19, 2026 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
EVP and CMO
1,912$483.75$924.9K41,516Feb 17, 2026Feb 19, 2026 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
EVP and CMO
3,804$487.76$1.86M38,053Feb 13, 2026Feb 18, 2026 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
EVP and CMO
2,145$468.41$1.00M41,857Feb 10, 2026Feb 12, 2026 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
PURCHASEGRANT
Stock grant
3,467——44,002Jan 22, 2026Jan 26, 2026 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
PURCHASEGRANT
Stock grant
7,866——40,535Jan 22, 2026Jan 26, 2026 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
EVP and CMO
4,962$479.61$2.38M32,669Feb 26, 2025Feb 28, 2025 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
EVP and CMO
3,310$483.28$1.60M37,631Feb 24, 2025Feb 26, 2025 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
EVP and CMO
1,912$463.46$886.1K40,941Feb 14, 2025Feb 19, 2025 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
PURCHASEGRANT
Stock grant
5,546——42,853Feb 12, 2025Feb 14, 2025 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
EVP and CMO
2,142$467.98$1.00M37,307Feb 10, 2025Feb 12, 2025 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
PURCHASEGRANT
Stock grant
5,928——39,449Feb 4, 2025Feb 6, 2025 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
PURCHASEGRANT
Stock grant
10,262——33,521Feb 4, 2025Feb 6, 2025 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE10b5-1
10b5-1 plan
2,280$476.75$1.09M23,259Aug 7, 2024Aug 8, 2024 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE10b5-1
10b5-1 plan
2,280$488.46$1.11M25,539Jul 24, 2024Jul 25, 2024 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE10b5-1
10b5-1 plan
2,280$487.34$1.11M27,819Jul 10, 2024Jul 12, 2024 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE10b5-1
10b5-1 plan
2,280$471.72$1.08M30,099Jun 26, 2024Jun 28, 2024 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE10b5-1
10b5-1 plan
2,280$478.00$1.09M32,379Jun 12, 2024Jun 13, 2024 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE10b5-1
10b5-1 plan
2,280$445.56$1.02M34,659May 29, 2024May 31, 2024 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
EVP and CMO
3,309$431.79$1.43M36,939Feb 23, 2024Feb 27, 2024 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
EVP and CMO
2,812$420.58$1.18M40,248Feb 20, 2024Feb 21, 2024 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
EVP and CMO
3,750$424.01$1.59M43,060Feb 16, 2024Feb 21, 2024 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
EVP and CMO
2,100$422.74$887.8K46,810Feb 9, 2024Feb 13, 2024 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
PURCHASEGRANT
Stock grant
5,928——48,910Feb 7, 2024Feb 8, 2024 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
PURCHASEGRANT
Stock grant
7,866——42,982Feb 6, 2024Feb 8, 2024 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
PURCHASEGRANT
Stock grant
5,814——35,116Feb 6, 2024Feb 8, 2024 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE10b5-1
10b5-1 plan
5,650$380.82$2.15M29,302Nov 14, 2023Nov 16, 2023 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE10b5-1
10b5-1 plan
5,651$355.92$2.01M34,952Oct 31, 2023Nov 2, 2023 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE10b5-1
10b5-1 plan
5,651$373.25$2.11M40,603Oct 17, 2023Oct 19, 2023 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE10b5-1
10b5-1 plan
5,651$345.28$1.95M46,254Oct 3, 2023Oct 5, 2023 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE10b5-1
10b5-1 plan
5,651$351.00$1.98M51,905Sep 19, 2023Sep 21, 2023 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE10b5-1
10b5-1 plan
5,651$352.66$1.99M57,556Sep 5, 2023Sep 7, 2023 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
EVP and CMO
3,308$289.12$956.4K63,207Feb 24, 2023Feb 28, 2023 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
EVP and CMO
3,750$292.85$1.10M66,515Feb 17, 2023Feb 22, 2023 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
EVP and CMO
4,992$298.26$1.49M70,265Feb 13, 2023Feb 14, 2023 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
EVP and CMO
2,707$294.33$796.8K75,257Feb 10, 2023Feb 14, 2023 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
PURCHASEGRANT
Stock grant
7,866——77,964Feb 1, 2023Feb 3, 2023 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
PURCHASEGRANT
Stock grant
10,262——70,098Feb 1, 2023Feb 3, 2023 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
PURCHASEGRANT
Stock grant
10,324——59,836Feb 1, 2023Feb 3, 2023 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
EVP and CMO
311$271.24$84.4K49,512May 31, 2022Jun 2, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
EVP and CMO
1,242$227.86$283.0K49,823Feb 24, 2022Feb 28, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
EVP and CMO
3,439$232.51$799.6K51,065Feb 17, 2022Feb 22, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
EVP and CMO
2,437$237.74$579.4K54,504Feb 10, 2022Feb 14, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
PURCHASEGRANT
Stock grant
11,628——46,679Feb 1, 2022Feb 3, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
PURCHASEGRANT
Stock grant
2,098——35,051Feb 1, 2022Feb 3, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
PURCHASEGRANT
Stock grant
10,262——56,941Feb 1, 2022Feb 3, 2022 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
EVP and CMO
311$210.04$65.3K32,953May 28, 2021Jun 2, 2021 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
EVP and CMO
311$217.57$67.7K33,264Feb 24, 2021Feb 26, 2021 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
EVP and CMO
2,367$214.16$506.9K33,575Feb 10, 2021Feb 12, 2021 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
PURCHASEGRANT
Stock grant
11,627——35,942Feb 3, 2021Feb 5, 2021 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
PURCHASEGRANT
Stock grant
10,324——24,315Feb 3, 2021Feb 5, 2021 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
EVP and CMO
311$282.74$87.9K13,991May 29, 2020Jun 2, 2020 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
SALE
EVP, GMDA
216$239.23$51.7K14,302Feb 24, 2020Feb 26, 2020 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
PURCHASEGRANT
Stock grant
10,323——14,518Feb 5, 2020Feb 7, 2020 ↗View →
VRTX
VERTEX PHARMACEUTICALS INC / MA
PURCHASEGRANT
Stock grant
2,098——4,195Feb 5, 2020Feb 7, 2020 ↗View →
Other insiders · VRTX
Loading peer insiders…
About this filer
CIK 0001790029
ROLE
EVP and CMO
PRIMARY
VRTX
COMPANIES
1
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001790029DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback